Servier Research Institute, Department of Rheumatology, 11 rue des Moulineaux, 92150 Suresnes, France.
Drug Discov Today. 2011 May;16(9-10):443-9. doi: 10.1016/j.drudis.2011.01.004. Epub 2011 Jan 22.
Osteoarthritis (OA), the most common and disabling form of arthritic disease, is characterized by a slow and progressive degeneration of articular cartilage. Its etiology is multifactorial and includes genetic predisposition, obesity and aging. In addition to the cartilage itself, OA also involves the surrounding tissues, including the synovium and the subchondral bone. This clinical heterogeneity complicates the identification of biomarkers that are crucial for prompt pharmacological intervention at the early stages of the disease and for monitoring treatment efficacy with higher sensitivity than existing imaging methods. In this review, we highlight the difficulties associated with OA diagnosis and discuss the most recent research efforts and successes for the identification of reliable OA biomarkers.
骨关节炎(OA)是最常见和致残性的关节炎疾病形式,其特征为关节软骨的缓慢进行性退化。其病因是多因素的,包括遗传易感性、肥胖和衰老。除了软骨本身,OA 还涉及周围组织,包括滑膜和软骨下骨。这种临床异质性增加了生物标志物的识别难度,生物标志物对于在疾病早期进行及时的药物干预以及比现有成像方法更敏感地监测治疗效果至关重要。在这篇综述中,我们强调了与 OA 诊断相关的困难,并讨论了用于鉴定可靠 OA 生物标志物的最新研究进展和成果。